Opyl Limited (ASX:OPL)

Improving healthcare outcomes through digital insights and patient engagement.

About Us

Opyl Limited is an innovative Australian company focused on applying artificial intelligence and digital tools to enhance healthcare outcomes. The company specialises in optimising clinical trials, improving patient recruitment, and providing advanced digital health solutions.

Company Overview

Opyl Limited is at the forefront of the digital health revolution, leveraging artificial intelligence and data analytics to address critical challenges in healthcare. The company focuses on enhancing the efficiency and effectiveness of clinical trials, improving patient engagement, and providing insights through digital health tools. Opyl’s services and platforms are designed to streamline clinical trial processes, reduce costs, and ensure better patient recruitment and retention, ultimately leading to more successful and timely healthcare solutions.

With a strong commitment to innovation, Opyl collaborates with healthcare providers, research institutions, and pharmaceutical companies to deliver state-of-the-art solutions. The company’s mission is to support the healthcare sector by providing advanced technologies that improve patient outcomes and operational efficiencies in clinical research and beyond.

Board & Managment

Saurabh Jain

Saurabh Jain

Executive Chairman

Saurabh Jain’s journey in the technology and business sectors is a testament to his entrepreneurial spirit and deep understanding of how technology can drive organisational change. Starting from humble beginnings as a software developer, Saurabh built a startup that successfully grew to over 2,500 customers before being acquired by Telstra. This initial success set the stage for his extensive career in SaaS commercialisation and senior executive roles, including serving as the CEO and Executive Director of Urbanise, an ASX-listed SaaS company. Alongside his professional achievements, Saurabh holds an undergraduate degree and two master’s degrees, providing a strong foundation for his strategic and innovative approach to business.

Saurabh is deeply passionate about helping organisations leverage technology to implement transformative changes. His board experience spans listed ASX companies, purpose-driven organisations, and private companies, where he brings his expertise in technology, commercialisation, and people management. As the Executive Chairman of Opyl Limited, Saurabh continues to drive the company’s vision of transforming healthcare through advanced digital solutions and artificial intelligence, guiding the organisation in navigating the intersection of technology and business strategy.

Damon Rasheed

Damon Rasheed

Executive Director

Damon Rasheed is a serial entrepreneur and pioneer in the tech industry, recognised for his ventures in machine learning and big data solutions. As the co-founder of several successful companies, including Advantage Data, Aurum Data, Foreshore Data, Rate Detective, iBus Media, and Rankster, Damon has consistently demonstrated his entrepreneurial acumen. His career began with the establishment of internet startups that leveraged big data analysis, showcasing his foresight in emerging technologies. Over the past two decades, he has developed expertise in machine learning, AI, econometrics, financial control, project management, economic consultancy, and digital marketing.

Currently serving as an executive board member of Opyl Limited (ASX: OPL), Damon continues to drive innovation in digital health and AI solutions. He developed TrialKey, an AI-driven clinical trial predictor with over 90% accuracy, aimed at revolutionising clinical trials by refining recommendations and optimising design and investment decisions. Damon's passion for econometrics and machine learning, coupled with his diverse background—including a regulatory stint with the Australian Government in anti-trust and advising successful ICOs like Bankera—positions him as a visionary leader shaping the future of tech and healthcare industries. His work has been featured on ABC radio, A Current Affair, Channel 7 news, and he is a frequent speaker at corporate and industry events.

Antanas Guoga

Antanas Guoga

Non-Executive Director

Antanas Guoga, widely known by his nickname ‘Tony G’, is a serial digital entrepreneur and venture capitalist renowned for his investments in start-ups in the digital space. As an entrepreneurship enabler, Antanas has founded, co-founded, and owned companies across Australia, the USA, and Lithuania, employing around 500 people. His ventures operate in emerging technologies such as AI and blockchain, reflecting his deep understanding of the challenges and opportunities in these fields. Antanas is also the founder of the biggest online poker news website, PokerNews.com, which grew into one of the largest online gaming affiliates globally.

Antanas’s distinguished career includes serving as a member of the European Parliament for Lithuania, where he advocated for a better entrepreneurial climate and improved business conditions. He launched the Blockchain Centre in Vilnius, Lithuania, connecting stakeholders across three continents with partner centres in Melbourne and Shanghai. Additionally, he founded CryptoNews.com and has been recognised with numerous awards, including the World Lithuanian of the Year prize in 2011 and inclusion in POLITICO’s influential lists. As a philanthropist, Antanas established his own fund in 2014, donating his European Parliament salary to charity and promoting youth entrepreneurship through events like #SWITCH!, the largest ICT and entrepreneurship event in the Baltic countries. Currently, Antanas serves as a non-executive director at Opyl Limited, contributing his vast expertise to the digital health and AI sectors.

Mark Simari

Mark Simari

Non-Executive Director

Mark Simari is a seasoned CEO, entrepreneur, and non-executive director with over 20 years of experience in finance, investment, equity capital markets, and mergers and acquisitions (M&A). His passion for turning ideas into profitable and sustainable commercial realities has driven his career, spanning diverse sectors and organisational types. Mark's expertise lies in evaluating both qualitative and quantitative factors to make strategic investment decisions that maximise financial returns and human capital potential. He has a strong focus on people, leveraging his understanding of numbers, concepts, and human dynamics to overcome the challenges inherent in growth, creating, integrating, and growing sustainable businesses through M&A activities.

Mark’s career highlights include serving as CFO and later non-executive director of DKN, where he led major recapitalisation and restructuring programs. Since 2007, he has provided visionary leadership to Paragon Care Ltd as MD and CEO, transforming it into a leading platform provider to the health and aged care markets. Additionally, as the Executive Chairman of Careteq Limited, Mark has driven the company's strategic M&A initiatives, positioning it as an emerging health-tech company listed on the ASX. His extensive board experience, including roles in not-for-profits, reflects his commitment to making a positive impact across various industries. Currently serving as a non-executive director at Opyl Limited, Mark continues to apply his strategic leadership to drive innovation and growth in the healthcare technology sector.

David Iilja

David Iilja

Company Secretary

David Iilja is a seasoned professional in the accounting and advisory sector, with a wealth of experience in providing business services, specialist tax, and consulting services to a diverse range of clients. As a key figure at DLK Advisory, David has been instrumental in partnering with family groups, SMEs, government entities, not-for-profits, and both large listed and unlisted companies. DLK Advisory is renowned for its comprehensive and structured service offerings, managing all compliance and advisory requirements, including financial, commercial, and lifestyle commitments.

David’s unique approach at DLK Advisory leverages a core satellite model, focusing on delivering tailored accounting and tax solutions that address both core needs and strategic goals. His expertise encompasses all phases of personal and business journeys, ensuring that clients receive the support they need to navigate complex financial landscapes. Currently serving as a non-executive director at Opyl Limited, David brings his extensive background in financial management and strategic advisory to enhance the company’s growth and operational efficiency in the digital health and AI sectors.

Opyl Limited

Follow Opyl Limited

By submitting your information below you can keep up to date with their relevant news and announcements.

Fields marked with * are required.

Name(Required)

Cancel